Moxifloxacin Vioser (Moxifloxacin Hydrochloride)

Moxifloxacin Hydrochloride, the active ingredient in Moxifloxacin Vioser, is a fluoroquinolone antibiotic presented as an intravenous formulation for injection use. It treats a range of serious bacterial infections in adult patients, including community‑acquired pneumonia, intra‑abdominal infections, and skin and soft‑tissue infections.

GNH USA supplies Moxifloxacin Vioser as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Moxifloxacin Vioser is used to treat bacterial infections affecting several organ systems. - Community‑Acquired Pneumonia: effective against typical and atypical pathogens in adult patients. - Complicated Intra‑Abdominal Infections: provides coverage for Gram‑negative and anaerobic bacteria. - Skin and Soft‑Tissue Infections: treats moderate to severe infections caused by susceptible organisms. - Acute Bacterial Sinusitis: used when oral therapy is unsuitable or ineffective.

Moxifloxacin may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea - Diarrhea - Headache - Dizziness - Rash - Elevated liver enzymes

Serious or Rare Side Effects: - Tendon rupture or tendinitis - QT interval prolongation and cardiac arrhythmias - Clostridioides difficile‑associated colitis - Severe allergic reactions (anaphylaxis, Stevens‑Johnson syndrome) - Hepatic failure - Peripheral neuropathy

When prescribing Moxifloxacin, clinicians should consider several precautionary measures to minimize risk. - Renal impairment: assess kidney function and adjust dose if necessary. - Hepatic impairment: monitor liver enzymes and use with caution. - QT prolongation risk: avoid in patients with known arrhythmias or electrolyte disturbances. - History of tendon disorders: discontinue if tendon pain or inflammation occurs. - Concomitant medications: review for potential interactions that may increase toxicity. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Moxifloxacin can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Antacids containing aluminum or magnesium: markedly reduce absorption. - Warfarin: may enhance anticoagulant effect, increasing bleeding risk. - Theophylline: can raise serum theophylline concentrations, leading to toxicity. - Other fluoroquinolones: additive risk of QT prolongation.

Moderate Interactions (Monitor Closely): - NSAIDs: may increase risk of central nervous system stimulation. - Corticosteroids: combined use raises tendon rupture risk. - Rifampin: may reduce moxifloxacin plasma levels, decreasing effectiveness. - Cyclosporine: may increase moxifloxacin concentrations.